For SOC + Cel and SOC + ZA + Cel, respectively, median time to starting Cel was 0.9 and 1.7 weeks after random assignment, and 6.5 and 7.1 weeks after starting HT; 14 and 17 patients, respectively, did not report starting Cel. The gene discussed is UBXN11; the disease is hematocrit.